Functional Study of a Carcinoma Associated Mucin MUC1
Functional Study of a Carcinoma Associated Mucin MUC1
批准号:
7048573
负责人:
SANDRA J GENDLER
金额:
$35.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-07-01 至 2009-02-28
关键词:
RNA interferencebiological signal transductionbreast neoplasmscarcinomaclinical researchcytoplasmcytoskeletal proteinscytoskeletongene expressiongenetically modified animalshuman subjectimmunoprecipitationlaboratory mousemammary glandmetastasismucinsneoplastic processoncogenespatient oriented researchphosphoprotein phosphataseprotein kinaseprotein protein interactionprotein structure functiontumor antigenstyrosineyeast two hybrid system
中文摘要
描述(由申请人提供):MUC1是一种在大多数肿瘤中过表达的肿瘤抗原,包括90%以上的乳腺癌。这种与细胞相关的粘蛋白高度o糖基化,在正常的分泌性上皮组织中低水平表达。MUC1的表达在肿瘤和转移中显著增加,细胞定位改变,在整个细胞周围发现。尽管MUC1不具有激酶活性,但细胞质尾部与多种信号传导和粘附调节蛋白相互作用。这些蛋白包括EGFR、erbB2、3和4、蛋白激酶C δ、C -src、gsk3 β、p120ctn、β -连环蛋白和Grb2。我们假设MUC1作为一种连接蛋白,将激酶、磷酸酶和其他连接蛋白聚集在一起,形成一个复合物,可能通过诱导有丝分裂发生和/或改变细胞的粘附状态导致肿瘤形成。MUC1在小鼠乳腺中的过度表达,模仿人类的情况,导致63%的小鼠随机形成肿瘤。90%的肿瘤转移到肺部。在野生型小鼠和表达MUC1的小鼠中未观察到肿瘤缺乏细胞质尾,提示细胞质尾对MUC1功能至关重要。为了进一步表征MUC1在乳腺及其他上皮组织中的致癌功能,我们提出:1)确定MUC1蛋白参与肿瘤发生的关键部分并确定下游信号通路,2)确定特定酪氨酸在MUC1细胞质尾部的作用,3)表征细胞质尾部与信号和肿瘤抑制蛋白的其他相互作用,4)确定MUC1是否在乳腺以外的组织中致癌。这些研究将显著增加我们对MUC1功能在上皮肿瘤转化、生长、侵袭和转移过程中的重要性的认识。
英文摘要
DESCRIPTION (provided by applicant): MUC1 is a tumor antigen that is overexpressed on most carcinomas, including greater than 90% of breast carcinomas. This cell associated mucin is highly O-glycosylated and expressed at low levels on normal secretory epithelial tissues. MUC1 expression is greatly increased and the cellular localization is altered in tumors and metastases, where it is found surrounding the entire cell. Although MUC1 does not possess kinase activity, the cytoplasmic tail interacts with multiple signaling and adhesion-regulating proteins. Among these proteins are EGFR, erbB2, 3, and 4, Protein Kinase C delta, c-src, GSK3beta, p120 ctn, beta-catenin, and Grb2. We hypothesize that MUC1 serves as an adaptor protein that brings together kinases, phosphatases, and other adaptor proteins to assemble a complex that leads to tumor formation, possibly by inducing mitogenesis, and/or changes in the adhesive state of the cell. Overexpression of MUC1 in the mouse mammary gland, to mimic what is seen in humans, resulted in stochastic tumor formation in 63% of mice. Ninety percent of tumors metastasized to the lung. No tumors were observed in wildtype mice or mice expressing MUC1 lacking the cytoplasmic tail, suggesting that the cytoplasmic tail is critical to the function. To further characterize the oncogenic function of MUC1 in the mammary gland and other epithelial tissues, we propose: 1) to determine the critical portions of the MUC1 protein involved in tumorigenesis and define down-stream signaling pathways, 2) to determine the role of specific tyrosines in the MUC1 cytoplasmic tail, 3) to characterize additional interactions of the cytoplasmic tail with signaling and tumor suppressor proteins, and 4) to determine if MUC1 is oncogenic in tissues other than the mammary gland. These studies will significantly increase our understanding of the importance of MUC1 function in epithelial tumors during transformation, growth, invasion and metastasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of IL-9 in Treg Biology and Tumor Immunity
-
批准号:8261694
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2011
-
负责人:SANDRA J GENDLER
-
依托单位:
Role of IL-9 in Treg Biology and Tumor Immunity
-
批准号:8624539
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2011
-
负责人:SANDRA J GENDLER
-
依托单位:
Role of IL-9 in Treg Biology and Tumor Immunity
-
批准号:8444712
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2011
-
负责人:SANDRA J GENDLER
-
依托单位:
Role of IL-9 in Treg Biology and Tumor Immunity
-
批准号:8027614
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2011
-
负责人:SANDRA J GENDLER
-
依托单位:
Preclinical and Clinical Studies of MUC1 Glycopeptide Vaccine Strategies in Breas
-
批准号:7737076
-
项目类别:
-
资助金额:$28.53万
-
财政年份:2008
-
负责人:SANDRA J GENDLER
-
依托单位:
Mechanism of Action of CpG-ODN in Generating Tumor Immunity in the Aged
-
批准号:8067772
-
项目类别:
-
资助金额:$30.11万
-
财政年份:2007
-
负责人:SANDRA J GENDLER
-
依托单位:
Optimization of Tumor Vaccines for the Aged
-
批准号:8039554
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2005
-
负责人:SANDRA J GENDLER
-
依托单位:
P-3: Preclinical and Clinical Studies of MUC1 Glycopeptide Vaccine Strategies in
-
批准号:6966178
-
项目类别:
-
资助金额:$28.77万
-
财政年份:2005
-
负责人:SANDRA J GENDLER
-
依托单位:
Optimization of Tumor Vaccines for the Aged
-
批准号:8206487
-
项目类别:
-
资助金额:$28.11万
-
财政年份:2005
-
负责人:SANDRA J GENDLER
-
依托单位:
Optimization of Tumor Vaccines for the Aged
-
批准号:8388776
-
项目类别:
-
资助金额:$26.42万
-
财政年份:2005
-
负责人:SANDRA J GENDLER
-
依托单位:
Optimization of Tumor Vaccines for the Aged
-
批准号:8586818
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2005
-
负责人:SANDRA J GENDLER
-
依托单位:
FUNCTIONAL STUDY OF A CARCINOMA-ASSOCIATED MUCIN MUC-1
-
批准号:2106821
-
项目类别:
-
资助金额:$22.06万
-
财政年份:1994
-
负责人:SANDRA J GENDLER
-
依托单位:
FUNCTIONAL STUDY OF A CARCINOMA ASSOCIATED MUCIN MUC1
-
批准号:6376083
-
项目类别:
-
资助金额:$34.22万
-
财政年份:1994
-
负责人:SANDRA J GENDLER
-
依托单位:
Functional Study of a Carcinoma Associated Mucin MUC1
-
批准号:7343228
-
项目类别:
-
资助金额:$34.61万
-
财政年份:1994
-
负责人:SANDRA J GENDLER
-
依托单位:
FUNCTIONAL STUDY OF A CARCINOMA-ASSOCIATED MUCIN MUC-1
-
批准号:2414333
-
项目类别:
-
资助金额:$27.41万
-
财政年份:1994
-
负责人:SANDRA J GENDLER
-
依托单位:
Functional Study of a Carcinoma Associated Mucin MUC1
-
批准号:6730392
-
项目类别:
-
资助金额:$36.5万
-
财政年份:1994
-
负责人:SANDRA J GENDLER
-
依托单位:
Functional Study of Mucin MUC1
-
批准号:8265226
-
项目类别:
-
资助金额:$36.12万
-
财政年份:1994
-
负责人:SANDRA J GENDLER
-
依托单位:
FUNCTIONAL STUDY OF A CARCINOMA-ASSOCIATED MUCIN MUC-1
-
批准号:2106819
-
项目类别:
-
资助金额:$19.52万
-
财政年份:1994
-
负责人:SANDRA J GENDLER
-
依托单位:
FUNCTIONAL STUDY OF A CARCINOMA-ASSOCIATED MUCIN MUC-1
-
批准号:2700567
-
项目类别:
-
资助金额:$28.49万
-
财政年份:1994
-
负责人:SANDRA J GENDLER
-
依托单位:
FUNCTIONAL STUDY OF A CARCINOMA ASSOCIATED MUCIN MUC1
-
批准号:6633190
-
项目类别:
-
资助金额:$35.3万
-
财政年份:1994
-
负责人:SANDRA J GENDLER
-
依托单位:
海外基金